Literature DB >> 9697979

Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility.

M Parkes1, J Satsangi, D Jewell.   

Abstract

Although the importance of genetic susceptibility to IBD has been established by epidemiological studies, the genes involved remain poorly characterized. Important candidate genes include those encoding the immunoregulatory cytokines IL-2 and IL-10. The aim of this study was to assess the contribution of the IL-2 and IL-10 genes to IBD susceptibility. One hundred and ninety-eight pairs of siblings with IBD were genotyped at dinucleotide repeat polymorphisms within the IL-2 and IL-10 genes, and data analysed by the affected sib-pair method of linkage analysis and the transmission disequilibrium test (TDT). A subset of 89 affected sibling pairs was genotyped at markers flanking the IL-2 gene as part of a genome-wide search. The IL-2 polymorphism showed no linkage to IBD overall, but modest evidence for linkage to the ulcerative colitis (UC) data set (P = 0.028). A microsatellite 4 cM distal to the IL-2 gene showed a similar distortion in the ulcerative colitis subgroup (P = 0.006). The TDT showed some distortion of allelic transmission for the IL-2 polymorphism in the UC group, but this did not reach statistical significance (P = 0.09). Results for the IL-10 polymorphism were not significant. Thus the gene encoding IL-2 may contribute to UC susceptibility, but the effect is modest and must await replication in other data sets. The IL-10 gene does not appear to contribute to the risk of developing UC or Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697979      PMCID: PMC1905008          DOI: 10.1046/j.1365-2249.1998.00625.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

2.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

3.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci.

Authors:  J D Terwilliger
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

4.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12.

Authors:  J Satsangi; M Parkes; E Louis; L Hashimoto; N Kato; K Welsh; J D Terwilliger; G M Lathrop; J I Bell; D P Jewell
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

7.  Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.

Authors:  E Breese; C P Braegger; C J Corrigan; J A Walker-Smith; T T MacDonald
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

9.  Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.

Authors:  H Asakura; M Tsuchiya; S Aiso; M Watanabe; K Kobayashi; T Hibi; K Ando; H Takata; S Sekiguchi
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

10.  Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire.

Authors:  C S Probert; V Jayanthi; A O Hughes; J R Thompson; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  8 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population.

Authors:  J Matsuzawa; K Sugimura; Y Matsuda; M Takazoe; K Ishizuka; T Mochizuki; S S Seki; O Yoneyama; H Bannnai; K Suzuki; T Honma; H Asakura
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease.

Authors:  Hongchao Lv; Yongshuai Jiang; Jin Li; Mingming Zhang; Zhenwei Shang; Jiajia Zheng; Xin Wu; Panpan Liu; Ruijie Zhang; Huimin Yu
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

Review 4.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.

Authors:  Vibeke Andersen; Anja Ernst; Jane Christensen; Mette Østergaard; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  BMC Med Genet       Date:  2010-05-28       Impact factor: 2.103

Review 6.  Harnessing regulatory T cells for the treatment of inflammatory bowel disease.

Authors:  Duke Geem; Akihito Harusato; Kyle Flannigan; Timothy L Denning
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

Review 7.  Genetic studies of Crohn's disease: past, present and future.

Authors:  Jimmy Z Liu; Carl A Anderson
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-05-06       Impact factor: 3.043

8.  Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients.

Authors:  Aristea Sideri; Kyriaki Bakirtzi; David Q Shih; Hon Wai Koon; Phillip Fleshner; Razvan Arsenescu; Violeta Arsenescu; Jerrold R Turner; Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.